Matthew D. Rousculp

Social SciencesMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Safety of the NVX-CoV2373 COVID-19 vaccine in randomized placebo-controlled clinical trials”.

Safety of the NVX-CoV2373 COVID-19 vaccine in randomized placebo-controlled clinical trials

Vaccine(2023)10.1016/j.vaccine.2023.05.016

N/A

0DataRank · unranked

11 citations

Karim Hegazy, Miranda R. Cai, Irene McKnight, Matthew D. Rousculp, Katia Alves +1 more

Safety of the NVX-CoV2373 COVID-19 Vaccine in Randomized Placebo-Controlled Clinical Trials

medRxiv(2023)10.1101/2023.02.24.23285601

N/A

0DataRank · unranked

1 citations

Karim Hegazy, Miranda R. Cai, Irene McKnight, Matthew D. Rousculp, Katia Alves +1 more